Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma; is the B-cell response preserved?

References

• Surveillance report of traumatic brain injury-related emergency department visits, hospitalizations, and deaths. Centers for Disease Control and Prevention; 2014.
   Google Scholar
• Baltas I, Tsoulfa S, Sakellariou P, Vogas V, Fylaktakis M, Kondodimou A. Posttraumatic meningitis: bacteriology, hydrocephalus, and outcome. Neurosurgery. 1994;35(3):1–9; discussion 6-7. doi:10.1227/00006123-199409000-00009.
   PubMed Web of Science ®Google Scholar
• Ter Horst L, Brouwer MC, van der Ende A, van de Beek D. Community-acquired bacterial meningitis in adults with cerebrospinal fluid leakage. Clin Infect Dis. 2020;70(11):2256–2261. doi:10.1093/cid/ciz649.
   PubMed Web of Science ®Google Scholar
• Eftekhar B, Ghodsi M, Nejat F, Ketabchi E, Esmaeeli B. Prophylactic administration of ceftriaxone for the prevention of meningitis after traumatic pneumocephalus: results of a clinical trial. J Neurosurg. 2004;101(5):757–761. doi:10.3171/jns.2004.101.5.0757.
   PubMed Web of Science ®Google Scholar
• Hand WL, Sanford JP. Posttraumatic bacterial meningitis. Ann Intern Med. 1970;72(6):869–874. doi:10.7326/0003-4819-72-6-869-72-6-869.
   PubMedGoogle Scholar
• Kallel H, Chelly H, Ghorbel M, Bahloul M, Ksibi H, Rekik N, Ben Mansour H, Bouaziz M. La Méningite post-traumatique : incidence, microbiologie et pronostic. Neuro-Chirurgie. 2006;52(5):397–406. doi:10.1016/S0028-3770(06)71238-3.
   PubMedGoogle Scholar
• Antimicrobial prophylaxis in neurosurgery and after head injury. Infection in neurosurgery working party of the British Society for antimicrobial chemotherapy. Lancet. 1994;344(8936):1547–1551. doi:10.1016/S0140-6736(94)90354-9.
   PubMed Web of Science ®Google Scholar
• Urwin G, Yuan MF, Hall LM, Brown K, Efstratiou A, Feldman RA. Pneumococcal meningitis in the North East Thames Region UK: epidemiology and molecular analysis of isolates. Epidemiol Infect. 1996;117(1):95–102. doi:10.1017/S0950268800001175.
   PubMedGoogle Scholar
• Henriques Normark B, Kalin M, Ortqvist A, Akerlund T, Liljequist BO, Hedlund J, Svenson S&, Zhou J, Spratt B&, Normark S, et al. Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis. 2001;184(7):861–869. doi:10.1086/323339.
   PubMed Web of Science ®Google Scholar
• Koelman DLH, Brouwer MC, van de Beek D. Resurgence of pneumococcal meningitis in Europe and Northern America. Clin Microbiol Infect. 2020;26(2):199–204. doi:10.1016/j.cmi.2019.04.032.
   PubMed Web of Science ®Google Scholar
• Kobayashi M. Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the advisory committee on immunization practices — United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(4):109–117. doi:10.15585/mmwr.mm7104a1.
   PubMed Web of Science ®Google Scholar
• Folkhälsomyndigheten. Uppdaterade rekommendationer om pneumokockvaccination till personer med mycket hög risk för allvarlig pneumokocksjukdom (maj 2022). 2022. https://www.folkhalsomyndigheten.se/contentassets/2805aff9924848e8a0ee3887eb0e9d0e/rekommendationer-pneumokockvaccination-hog-risk-maj-2022.pdf.
   Google Scholar
• Hotchkiss RS, Monneret G, Payen D. Sepsis-Induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862–874. doi:10.1038/nri3552.
   PubMed Web of Science ®Google Scholar
• Singh S, Singh P, Singh G. Systemic inflammatory response syndrome outcome in surgical patients. Indian J Surg. 2009;71(4):206–209. doi:10.1007/s12262-009-0062-z.
   PubMed Web of Science ®Google Scholar
• Cheadle WG, Pemberton RM, Robinson D, Livingston DH, Rodriguez JL, Polk HC, Jr. Lymphocyte subset responses to trauma and sepsis. J Trauma. 1993;35(6):844–849. doi:10.1097/00005373-199312000-00007.
   PubMedGoogle Scholar
• Kasten KR, Goetzman HS, Reid MR, Rasper AM, Adediran SG, Robinson CT, Cave CM, Solomkin JS, Lentsch AB, Johannigman JA, et al. Divergent adaptive and innate immunological responses are observed in humans following blunt trauma. BMC Immunol. 2010;11(1):4. doi:10.1186/1471-2172-11-4.
   PubMedGoogle Scholar
• Vourc’-H M, Roquilly A, Asehnoune K. Trauma-induced damage-associated molecular patterns-mediated remote organ injury and immunosuppression in the acutely ill patient. Front Immunol. 2018;9:1330. doi:10.3389/fimmu.2018.01330.
   PubMed Web of Science ®Google Scholar
• Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005;6(10):775–786. doi:10.1038/nrn1765.
   PubMed Web of Science ®Google Scholar
• Meert KL, Long M, Kaplan J, Sarnaik AP. Alterations in immune function following head injury in children. Crit Care Med. 1995;23(5):822–828. doi:10.1097/00003246-199505000-00008.
   PubMed Web of Science ®Google Scholar
• Miller CH, Quattrocchi KB, Frank EH, Issel BW, Wagner FC, Jr. Humoral and cellular immunity following severe head injury: review and current investigations ‡. Neurol Res. 1991;13(2):117–124. doi:10.1080/01616412.1991.11739977.
   PubMedGoogle Scholar
• Hedberg AL, Pauksens K, Ronne-Engstrom E, Lundberg M, Johansson B, Kayhty H, Sjölin J. Lower response to early T-cell-dependent vaccination after neurotrauma or neurosurgery in adults. J Infect. 2015;70(6):577–584. doi:10.1016/j.jinf.2014.12.014.
   PubMed Web of Science ®Google Scholar
• Hedberg AL, Pauksens K, Enblad P, Soderberg J, Johansson B, Kayhty H, Sjölin J. Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery. Vaccine. 2017;35(6):909–915. doi:10.1016/j.vaccine.2016.12.065.
   PubMed Web of Science ®Google Scholar
• Simell B, Lahdenkari M, Reunanen A, Kayhty H, Vakevainen M. Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins. Clin Vaccine Immunol. 2008;15(9):1391–1397. doi:10.1128/CVI.00110-08.
   PubMed Web of Science ®Google Scholar
• Makela PH, Kayhty H, Leino T, Auranen K, Peltola H, Ekstrom N, Eskola J. Long-Term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine. Vaccine. 2003;22(2):287–292. doi:10.1016/S0264-410X(03)00524-3.
   PubMed Web of Science ®Google Scholar
• Kayhty H, Peltola H, Karanko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis. 1983;147(6):1100. doi:10.1093/infdis/147.6.1100.
   PubMed Web of Science ®Google Scholar
• D’-Haese JG, Demir IE, Friess H, Ceyhan GO. Fractalkine/cx3cr1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. Expert Opin Ther Targets. 2010;14(2):207–219. doi:10.1517/14728220903540265.
   PubMed Web of Science ®Google Scholar
• Owen JA, Punt J, Stranford SA. Immunology. 2013.
   Google Scholar
• Jawa RS, Anillo S, Huntoon K, Baumann H, Kulaylat M. Interleukin-6 in surgery, trauma, and critical care part II: clinical implications. J Intensive Care Med. 2011;26(2):73–87. doi:10.1177/0885066610384188.
   PubMedGoogle Scholar
• Yui S, Nakatani Y, Mikami M. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull. 2003;26(6):753–760. doi:10.1248/bpb.26.753.
   PubMed Web of Science ®Google Scholar
• Paffrath T, Lefering R, Flohe S, TraumaRegister DGU. How to define severely injured patients? – an Injury Severity Score (ISS) based approach alone is not sufficient. Injury. 2014;45(Suppl 3):S64–9. doi:10.1016/j.injury.2014.08.020.
   PubMedGoogle Scholar
• Li G, Liang Q, Shi J, Hu Y, Li H, Wei W, Zhu F, Ye Q. Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in 2 to 70 year old healthy people in China: a phase III double blind, randomized clinical trial. Hum Vaccines Immunother. 2015;11(3):699–703. doi:10.1080/21645515.2015.1011015.
   PubMed Web of Science ®Google Scholar
• Grabenstein JD, Manoff SB. Pneumococcal polysaccharide 23-valent vaccine: long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults. Vaccine. 2012;30(30):4435–4444. doi:10.1016/j.vaccine.2012.04.052.
   PubMed Web of Science ®Google Scholar
• Hoyt DB, Ozkan AN, Hansbrough JF, Marshall L, VanBerkum-Clark M. Head injury: an immunologic deficit in T-cell activation. J Trauma. 1990;30(7):759–766; discussion 66-7. doi:10.1097/00005373-199007000-00001.
   PubMedGoogle Scholar
• Quattrocchi KB, Frank EH, Miller CH, Dull ST, Howard RR, Wagner FC, Jr. Severe head injury: effect upon cellular immune function ‡. Neurol Res. 1991;13(1):13–20. doi:10.1080/01616412.1991.11739959.
   PubMedGoogle Scholar
• Roquilly A, Braudeau C, Cinotti R, Dumonte E, Motreul R, Josien R, Asehnoune K. Impaired blood dendritic cell numbers and functions after aneurysmal subarachnoid hemorrhage. PloS One. 2013;8(8):e71639. doi:10.1371/journal.pone.0071639.
   PubMed Web of Science ®Google Scholar
• Pollard AJ, Perrett KP, Beverley PC. Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines. Nat Rev Immunol. 2009;9(3):213–220. doi:10.1038/nri2494.
   PubMed Web of Science ®Google Scholar
• Marits P, Wikstrom AC, Popadic D, Winqvist O, Thunberg S. Evaluation of T and B lymphocyte function in clinical practice using a flow cytometry based proliferation assay. Clin Immunol. 2014;153(2):332–342. doi:10.1016/j.clim.2014.05.010.
   PubMed Web of Science ®Google Scholar
• Livingston DH, Appel SH, Wellhausen SR, Sonnenfeld G, Polk HC, Jr. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg. 1988;123(11):1309–1312. doi:10.1001/archsurg.1988.01400350023002.
   PubMedGoogle Scholar
• West SD, Mold C. Monocyte deactivation correlates with injury severity score, but not with heme oxygenase-1 levels in trauma patients. J Surg Res. 2012;172(1):5–10. doi:10.1016/j.jss.2011.04.016.
   PubMed Web of Science ®Google Scholar
• Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, et al. Granulocyte–macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression. Am J Respir Crit Care Med. 2009;180(7):640–648. doi:10.1164/rccm.200903-0363OC.
   PubMed Web of Science ®Google Scholar
• Song JY, Moseley MA, Burton RL, Nahm MH. Pneumococcal vaccine and opsonic pneumococcal antibody. J Infect Chemother. 2013;19(3):412–425. doi:10.1007/s10156-013-0601-1.
   PubMed Web of Science ®Google Scholar
• Bryant KA, Frenck R, Gurtman A, Rubino J, Treanor J, Thompson A, Jones TR, Sundaraiyer V, Baxter LM, Gruber WC, et al. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18–49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine. Vaccine. 2015;33(43):5854–5860. doi:10.1016/j.vaccine.2015.08.080.
   PubMed Web of Science ®Google Scholar
• Mueller SW, Baumgartner LJ, MacLaren R, Neumann R, Wiktor AJ, Kiser TH, Lindberg G, Cava L, Fish DN, Janoff EN, et al. Divergent humoral responses to 23-valent pneumococcal polysaccharide vaccine in critically-ill burn and neurosurgical patients. PloS One. 2018;13(5):e0197037. doi:10.1371/journal.pone.0197037.
   PubMed Web of Science ®Google Scholar
• Cook IF, Pond D, Hartel G. Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults. Vaccine. 2007;25(25):4767–4774. doi:10.1016/j.vaccine.2007.04.017.
   PubMed Web of Science ®Google Scholar
• Carlsson RM, Claesson BA, Kayhty H, Selstam U, Iwarson S. Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine. Vaccine. 1999;18(5–6):468–478. doi:10.1016/S0264-410X(99)00238-8.
   PubMed Web of Science ®Google Scholar